Share on :

Asset Summary

Daily Performance Report for INCY ETF: Dec 9, 2024

Summary: The day started with INCY ETF opening at $76.51 and closing at $72.11. The ETF showed weakness throughout the day, with the highest price observed at $76.51 and the lowest at $71.8. The underlying asset had a trading range of $4.71 Overall, it was a negative trading day for INCY ETF, reflecting investor pessimism and market activity.

Change in Closing Price: There was a net decrease of $-4.40 or -5.75% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for INCY ETF was 1,641,143 units during Dec 9, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $76.51.

Highest Price: The highest price observed during the day was $76.51.

Lowest Price: The lowest price observed during the day was $71.8.

Closing Price: The day ended at $72.11.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Transform Your INCY Trading Now

Empower your trading with RankMyTrade. Our comprehensive platform delivers precise analysis and strategic insights for INCY, designed to improve your trading outcomes. Start optimizing your trades today and unlock new opportunities with our advanced system!

Discover More Now

Frequently Asked Questions

Incyte employs a science-driven approach, focusing on molecularly targeted therapies to address unmet medical needs.

Incyte is headquartered in Wilmington, Delaware, USA.

Incyte offers additional therapies for various conditions, including ruxolitinib for myelofibrosis and graft-versus-host disease.

Investors can visit Incyte’s official website for detailed information on financial performance and corporate updates.

Incyte was founded in 1991 and has been dedicated to oncology and other serious diseases.

Incyte’s flagship product is Jakafi (ruxolitinib), used to treat certain types of blood cancer.

Incyte’s mission is to innovate and deliver therapies that improve the lives of patients with serious diseases.

Yes, Incyte is heavily invested in R&D to discover and develop new therapies for serious diseases.

Incyte engages with patient communities to provide support and educational resources about their conditions and treatments.

Incyte partners with other pharmaceutical companies and academic institutions to enhance its research capabilities.

Empower Your INCY Trading Now

Revolutionize your investment in INCY with RankMyTrade Platform’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Elevate your trading approach instantly with RankMyTrade Platform now and achieve better trading outcomes!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs